US 9902703
Somatostatin modulators and uses thereof
granted A61PA61P5/02
Quick answer
US patent 9902703 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P5/02